A large-scale, multicentre study has shown that emergency body cooling does not improve survival rates or reduce brain injury in infants and children with out-of-hospital cardiac arrest more than normal temperature control.
Therapeutic hypothermia, or whole body cooling, can improve survival and health outcomes for adults after cardiac arrest and also for newborns with brain injury due to a lack of oxygen at birth. But, until now, this treatment has not been studied in infants or children admitted to hospitals with cardiac arrest.
“Our results show that therapeutic hypothermia is no more effective for treating children after out-of-hospital cardiac arrest than maintaining body temperature within the normal range, ” said co-principal investigator Dr Frank W Moler, a professor in the department of paediatrics and communicable diseases at University of Michigan’s CS Mott Children’s Hospital. “Both treatments help to control fever and result in similar outcomes for patients.”
The study included 295 participants between 2 days and 18 years old who were admitted to children’s hospitals for cardiac arrest, required chest compressions for at least two minutes and remained dependent on mechanical ventilation to breathe. After their parents or guardians provided consent, children were randomly assigned to one of the two treatment groups. One group received body cooling for two days followed by three days of normal temperature control. Another group received normal temperature control for five days.
During the treatment, study participants lay between special blankets. Pumps circulate water through tubes in the blankets to maintain specific body temperature ranges: either a lower range of 89.6ºF–93.2ºF or a normal range of 96.8ºF–99.5ºF. One year after treatment, researchers observed no difference in survival or cognitive function between groups.
Out-of-hospital cardiac arrest in infants and children typically results from causes such as strangulation, drowning, or trauma. A separate study by the same researchers is examining body cooling in hospitalised patients who suffer cardiac arrest, typically as a complication of a medical condition. A goal of both studies is preventing fever, which commonly occurs after cardiac arrest and can lead to more severe outcomes.
“The findings from these studies may well lead to evidence-based guidelines that will improve the quality and rates of pediatric cardiac arrest survival by using better treatments,” said co-principal investigator Dr J Michael Dean, professor of pediatrics and chief of the division of pediatric critical care medicine at the University of Utah School of Medicine, Salt Lake City. “Our hope is to identify the most effective treatment for preventing neurological damage or death in infants and children who suffer cardiac arrest.”
The studies are part of the Therapeutic Hypothermia after Pediatric Cardiac Arrest (THAPCA) trials, a six-year effort that is the largest examination of therapeutic hypothermia in children other than newborns for any health condition to date.